Features Roivant raised USD 200 million, now valued at USD 7 billion The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an…Jérémie Meyer19.11.2018
Interviews “We will not shy away from taking risks” In 2016, Roivant Sciences established their global headquarters in Basel. Roivant founder and CEO Vivek Ramaswamy talked to us about his fast growing company, his priorities…Jérémie Meyer04.07.2018
